MentionFox
Home › Layoffs › X4 Pharmaceuticals, Inc
SEC filings · Form 8-K, Item 2.05

X4 Pharmaceuticals, Inc layoffs and restructuring

Before you join, sell to or invest in X4 Pharmaceuticals, Inc

MentionFox check on X4 Pharmaceuticals, Inc: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/x4-pharmaceuticals

  • Note: Layoff plan disclosed Feb 2025 (about 43 employees) (filing)

New since last check: Layoff plan disclosed Feb 2025 (about 43 employees) (filing, first seen 14 November 2026).

Check X4 Pharmaceuticals, Inc before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about X4 Pharmaceuticals, Inc?

Every exit or restructuring plan X4 Pharmaceuticals, Inc reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 43 employees are affected, about 30% of its workforce, according to X4 Pharmaceuticals, Inc's latest layoff filing, on February 6, 2025. As of November 15, 2026, X4 Pharmaceuticals, Inc has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, February 6, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Bain Capital Life Sciences Fund, L.P. also filed stake reports on 2 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of X4 Pharmaceuticals, Inc.

Free to see. No signup.

People from X4 Pharmaceuticals, Inc who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the X4 Pharmaceuticals, Inc layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest, employees43
Latest filing2025-02-06

X4 Pharmaceuticals, Inc reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did X4 Pharmaceuticals have layoffs in 2025? What its filings say

X4 Pharmaceuticals, Inc (CIK 1501697) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-02-06

Employees affected

In connection with this shift in operational focus and strategic restructuring, the Company expects to implement a net reduction of its employee headcount by 43 employees, or approximately 30% of the Company's employees.

Locations

The strategic restructuring activities include (i) discontinuing of research efforts, (ii) closing the Company's facility in Vienna, Austria, (iii) pausing pre-clinical drug candidate programs, (iv) scaling the U.S. commercial field team and supporting roles across the Company and (v) streamlining other spending to support the ongoing clinical development of mavorixafor for the larger population of those with chronic neutropenia.

Expected charges

The Company estimates that it will incur charges of approximately $3.0 million for severance and other employee termination-related costs, primarily in the first quarter of 2025.

Also on the record for X4 Pharmaceuticals, Inc

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G/A, by Coastlands Capital LP9.99% of the class5%+ stakesSource
October 7, 2026Stake report, Schedule 13G/A, by FMR LLC4.6% of the class5%+ stakesSource
September 21, 2026Stake report, Schedule 13G, by Venrock Healthcare Capital Partners III, L.P.5.6% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Deep Track Capital, LP8.33% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by Perceptive Advisors LLC8.1% of the class5%+ stakesSource
July 30, 2026Stake report, Schedule 13G, by BlackRock, Inc.5.9% of the class5%+ stakesSource
July 1, 2026Leadership change: Kelly Gold appointed, Director—Leadership changesSource
May 15, 2026Stake report, Schedule 13G/A, by Perceptive Advisors LLC7.3% of the class5%+ stakesSource
March 6, 2026Stake report, Schedule 13G/A, by Morgan Stanley10.2% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G, by Saturn V Capital Management LP7.36% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by BCLS II Equity Opportunities, LP7.43% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by BVF PARTNERS L P/IL3.9% of the class5%+ stakesSource

Keep reading

More on X4 Pharmaceuticals, Inc and the records around it.

X4 Pharmaceuticals, Inc elsewhere on the record

Companies that share a holder

What do you want to do with X4 Pharmaceuticals, Inc?

Want the whole picture on X4 Pharmaceuticals, Inc?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on X4 Pharmaceuticals, Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on X4 Pharmaceuticals, Inc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 33 records.

Tools for this story

Each opens in a new tab, filled in for X4 Pharmaceuticals, Inc. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/x4-pharmaceuticals
Last updated 2026-11-15
X4 Pharmaceuticals, Inc layoffs 2025: about 43 jobs (8-K). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/x4-pharmaceuticals